RedHill Biopharma shares jump as Ebola treatment shows promise

RedHill Biopharma shares jump as Ebola treatment shows promise

Source: 
Marketwatch
snippet: 

RedHill Biopharma Ltd. American depositary receipts RDHL, -5.72% climbed 10% premarket on Wednesday after the company said two of its experimental drugs, when individually combined with remdesivir, showed promise in combating the Ebola virus.